TSXV:CLAS.H - Post by User
Comment by
Litemuppon May 17, 2018 6:10pm
123 Views
Post# 28049205
RE:Listen up....I called the last NR
RE:Listen up....I called the last NRU sound like an investment firm outfit. Either way I agree with the whole pharmaceutical advantage. Some of these big companies have pain meds in portfolios worth billions. I happen to be on 2 pain medicines from Pfizer and they are both blockbuster drugs celebrex and lyrica.
busy4life wrote: This is getting ready for a big run. I am tight with a few insiders. A lot of stuff happening behind the scenes and KALY has already gotten attention from some tier 2 pharma compairs, names of which I cannot disclose. If all goes well this will get halted and straight bought out. Pharma is itching to get into cannabis treatments and instead of reinventing the wheels they will start acquiring boutique research companies like KALY that are targeting medical cannabis therapies. Their biggest advantage is the Israel connection. Good luck.